Editorial

1. Biology and therapy of urological cancer metastasis

Review

1. Non-invasive actionable biomarkers for metastatic prostate cancer
2. Role of androgen receptor splice variants in prostate cancer metastasis
3. Adaptive pathways and emerging strategies overcoming treatment resistance in castration resistant prostate cancer
4. Immune phenotypes of prostate cancer cells: Evidence of epithelial immune cell-like transition?
5. The evolving landscape of prostate cancer stem cell:Therapeutic implications and future challenges
6. Understanding the biology of urothelial cancer metastasis
7. Cultured circulating tumor cells and their derived xenografts for personalized oncology
8. Applications of circulating tumor cells for prostate cancer
9. Intrinsic subtypes and bladder cancer metastasis
10. Novel immunotherapy approaches for metastatic urothelial and renal cell carcinoma
11. Developing immunotherapy strategies in the treatment of prostate cancer
12. Metastasis in renal cell carcinoma:Biology and implications for therapy

Original Article

1. Mismatch repair enzyme expression in primary and castrate resistant prostate cancer
2. Specific bone region localization of osteolytic versus osteoblastic lesions in a patient-derived xenograft model of bone metastatic prostate cancer